TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages

被引:20
|
作者
Dabla, Ankita [1 ]
Liang, Yi Chu [1 ]
Rajabalee, Nusrah [1 ]
Irwin, Courtney [1 ]
Moonen, Carolyn G. J. [1 ]
Willis, Jessie, V [1 ]
Berton, Stefania [1 ]
Sun, Jim [1 ,2 ]
机构
[1] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[2] Univ Ottawa, Ctr Infect Immun & Inflammat, Ottawa, ON, Canada
来源
MBIO | 2022年 / 13卷 / 04期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Mycobacterium tuberculosis; triggering receptor expressed on myeloid cells; TREM2; macrophage cell death; type I interferon; IFN; reactive oxygen species; phagocytosis; MYELOID CELLS 2; MICROGLIAL RESPONSE; INTERFERON-GAMMA; REACTIVE-OXYGEN; RECEPTOR; INNATE; RECOGNITION; PHAGOCYTOSIS; EXPRESSION; CLEARANCE;
D O I
10.1128/mbio.01456-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycobacterium tuberculosis is one of the most ancient bacterial pathogens and remains the leading cause of death from a single bacterial agent. The success of M. tuberculosis relies greatly on its ability to parasitize and disable its host macrophages. Macrophage surface receptors are critical for pathogen defense, as they are the gatekeepers for pathogen entry and sensing, which trigger robust immune responses. TREM2 (triggering receptor expressed on myeloid cells 2) is a transmembrane surface receptor that mediates anti-inflammatory immune signaling. A recent study showed that TREM2 is a receptor for mycolic acids in the mycobacterial cell wall and inhibits macrophage activation. However, the underlying functional mechanism of how TREM2 regulates the macrophage antimycobacterial response remains unclear. Here, we show that Mycobacterium tuberculosis, the causative agent for tuberculosis, specifically binds to human TREM2 to disable the macrophage antibacterial response. Live but not killed mycobacteria specifically trigger the upregulation of TREM2 during macrophage infection through a mechanism dependent on STING (the stimulator of interferon genes). TREM2 facilitated uptake of M. tuberculosis into macrophages and is responsible for blocking the production of tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and reactive oxygen species (ROS), while enhancing the production of interferon-beta (IFN-beta) and IL-10. TREM2-mediated blockade of ROS production promoted the survival of M. tuberculosis within infected macrophages. Consistent with this, genetic deletion or antibody-mediated neutralization of TREM2 reduced the intracellular survival of M. tuberculosis through enhanced production of ROS. Importantly, inhibition of type I IFN signaling in TREM2-overexpressing macrophages restored the ability of these cells to produce inflammatory cytokines and ROS, resulting in normal levels of intracellular bacteria killing. Collectively, our study identifies TREM2 as an attractive host receptor for host-directed antimycobacterial therapeutics. IMPORTANCE Mycobacterium tuberculosis is one of the most ancient bacterial pathogens and remains the leading cause of death from a single bacterial agent. The success of M. tuberculosis relies greatly on its ability to parasitize and disable its host macrophages. Previous studies have found that M. tuberculosis uses its unique cell wall lipids to manipulate the immune response by binding to specific surface receptors on macrophages. Our study reveals that M. tuberculosis binds to TREM2, an immunomodulatory receptor expressed on macrophages, to facilitate a "silent" mode of entry. Increased levels of TREM2 triggered by intracellular sensing of M. tuberculosis promoted the intracellular survival of M. tuberculosis through type I IFN-driven inhibition of reactive oxygen species (ROS) and proinflammatory cytokine production. Importantly, deletion of TREM2 reversed the effects of "silent" entry and resulted in increased production of inflammatory cytokines, generation of ROS, and cell death. As such, antibody-mediated or pharmacological targeting of TREM2 could be a promising strategy for novel treatments against M. tuberculosis infection.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Trem2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
    Xiang, X.
    Chen, X.
    Zhao, Y.
    Huang, Y.
    Zhang, H.
    Kettenmann, H.
    [J]. GLIA, 2023, 71 : E1165 - E1165
  • [2] TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
    Chen, Xuezhen
    Zhao, Yue
    Huang, Yimin
    Zhu, Kaichuan
    Zeng, Fan
    Zhao, Junyi
    Zhang, Huaqiu
    Zhu, Xinzhou
    Kettenmann, Helmut
    Xiang, Xianyuan
    [J]. GLIA, 2023, : 2679 - 2695
  • [3] TREM2 activation promotes remyelination
    Heather Wood
    [J]. Nature Reviews Neurology, 2020, 16 : 522 - 522
  • [4] TREM2 activation promotes remyelination
    Wood, Heather
    [J]. NATURE REVIEWS NEUROLOGY, 2020, 16 (10) : 522 - 522
  • [5] Immune evasion and provocation by Mycobacterium tuberculosis
    Pallavi Chandra
    Steven J. Grigsby
    Jennifer A. Philips
    [J]. Nature Reviews Microbiology, 2022, 20 : 750 - 766
  • [6] Immune evasion and provocation by Mycobacterium tuberculosis
    Chandra, Pallavi
    Grigsby, Steven J.
    Philips, Jennifer A.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2022, 20 (12) : 750 - 766
  • [7] Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages:: A potential novel mechanism of immune evasion by Mycobacterium tuberculosis?
    Mustafa, T
    Phyu, S
    Nilsen, R
    Bjune, G
    Jonsson, R
    [J]. INFLAMMATION, 1999, 23 (06) : 507 - 521
  • [8] Increased Expression of Fas Ligand on Mycobacterium tuberculosis Infected Macrophages: A Potential Novel Mechanism of Immune Evasion by Mycobacterium tuberculosis?
    Tehmina Mustafa
    Sabai Phyu
    Rune Nilsen
    Gunnar Bjune
    Roland Jonsson
    [J]. Inflammation, 1999, 23 (6) : 507 - 521
  • [9] INVESTIGATING TREM2 MACROPHAGES IN CHRONIC KIDNEY DISEASE
    Trivioli, Giorgio
    Richoz, Nathan
    Subramanian, Ayshwarya
    Vernon, Katherine
    Trotter, Patrick
    Zhou, Yiming
    Shaw, Jillian
    Greka, Anna
    Clatworthy, Menna
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1245 - I1247
  • [10] Stealth Strategies of Mycobacterium tuberculosis for Immune Evasion
    Naeem, Muhammad Ahsan
    Ahmad, Waqas
    Tyagi, Rohit
    Akram, Qaiser
    Younus, Muhammad
    Liu, Xilin
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 41 : 597 - 616